Suppr超能文献

慢性阻塞性肺疾病患者体内抗CD80自身抗体

Autoantibodies against CD80 in patients with COPD.

作者信息

Luo Xu Min, Liu Xin Yan, Tang Ji Hong, Yang Wei, Ni Zhen Hua, Chen Qing Ge, Wang Xiongbiao

机构信息

Department of Respiratory Medicine, Putuo Hospital Affilated Shanghai University of Traditional Chinese Medicine , Shanghai, China.

出版信息

Clin Transl Immunology. 2016 Oct 7;5(10):e103. doi: 10.1038/cti.2016.57. eCollection 2016 Oct.

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammation disorder and possibly an autoimmune disease. The components of the autoimmune response in the circulatory system are of considerable interest to clinicians. Because aberrations of costimulation status have been noted in COPD, the presence of autoantibodies to B7 costimulatory factor CD80 were investigated in a cohort of patients. Recombinant rs1CD80 (lacking the transmembrane domain of CD80) was used for Western blot analysis and ELISA to investigate the presence of autoantibodies in sera of patients with stable COPD and in controls without COPD. Cytokines IL-6 and IL-8 were detected using ELISA. Western blot revealed a specific band reacting to rs1CD80 by diluting sera pool of patients, which indicated the existence of autoantibodies to CD80. The serum level of anti-rs1CD80 was higher in patients with COPD than in controls(=0.0185) and was positively correlated to the serum level of IL-6 (=0.797, <0.001) and IL-8 (=0.608, <0.001). There was a tendency that more higher level of anti-rs1CD80, more severe COPD stage. The existence of autoantibodies to costimulatory factor CD80 may suggest a pathogenic role of costimulatory factors in COPD.

摘要

慢性阻塞性肺疾病(COPD)是一种炎症性疾病,也可能是自身免疫性疾病。循环系统中自身免疫反应的组成部分引起了临床医生的极大兴趣。由于在COPD中已注意到共刺激状态异常,因此在一组患者中研究了针对B7共刺激因子CD80的自身抗体的存在情况。使用重组rs1CD80(缺乏CD80的跨膜结构域)进行蛋白质印迹分析和酶联免疫吸附测定(ELISA),以研究稳定期COPD患者和无COPD对照者血清中自身抗体的存在情况。使用ELISA检测细胞因子白细胞介素-6(IL-6)和白细胞介素-8(IL-8)。蛋白质印迹显示,通过稀释患者血清池可出现一条与rs1CD80反应的特异性条带,这表明存在针对CD80的自身抗体。COPD患者血清中抗rs1CD80水平高于对照组(=0.0185),且与IL-6血清水平呈正相关(=0.797,<0.001)以及与IL-8血清水平呈正相关(=0.608,<0.001)。存在一种趋势,即抗rs1CD80水平越高,COPD阶段越严重。共刺激因子CD80自身抗体的存在可能表明共刺激因子在COPD中具有致病作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6515/5099427/7f8e813ffb99/cti201657f1.jpg

相似文献

1
Autoantibodies against CD80 in patients with COPD.
Clin Transl Immunology. 2016 Oct 7;5(10):e103. doi: 10.1038/cti.2016.57. eCollection 2016 Oct.
2
Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD.
Immunol Lett. 2010 Feb 16;128(2):131-6. doi: 10.1016/j.imlet.2009.12.017. Epub 2009 Dec 28.
3
Dendritic cells and Th17/Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease.
Biomed Pharmacother. 2018 Dec;108:1141-1151. doi: 10.1016/j.biopha.2018.09.113. Epub 2018 Oct 1.
8
Differential expression of sputum and serum autoantibodies in patients with chronic obstructive pulmonary disease.
Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1169-L1182. doi: 10.1152/ajplung.00518.2020. Epub 2021 Apr 28.

引用本文的文献

1
Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2023 Dec 5;18:2867-2886. doi: 10.2147/COPD.S434601. eCollection 2023.
2
Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant.
Front Immunol. 2021 Aug 11;12:711102. doi: 10.3389/fimmu.2021.711102. eCollection 2021.
5
Autoantibodies in Chronic Obstructive Pulmonary Disease.
Front Immunol. 2018 Jan 25;9:66. doi: 10.3389/fimmu.2018.00066. eCollection 2018.

本文引用的文献

1
Immune response in chronic obstructive pulmonary disease.
Expert Rev Clin Immunol. 2013 Sep;9(9):821-33. doi: 10.1586/1744666X.2013.828875.
2
Molecular mechanisms of T cell co-stimulation and co-inhibition.
Nat Rev Immunol. 2013 Apr;13(4):227-42. doi: 10.1038/nri3405. Epub 2013 Mar 8.
4
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
5
New insights into the immunology of chronic obstructive pulmonary disease.
Lancet. 2011 Sep 10;378(9795):1015-26. doi: 10.1016/S0140-6736(11)60988-4.
6
CD4+/CD25+ cells in systemic inflammation in COPD.
Scand J Immunol. 2011 Jan;73(1):59-65. doi: 10.1111/j.1365-3083.2010.02474.x.
7
Inflammatory markers in COPD.
Clin Respir J. 2008 Oct;2 Suppl 1:84-7. doi: 10.1111/j.1752-699X.2008.00089.x.
8
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1179-88. doi: 10.1164/rccm.200904-0552OC. Epub 2009 Sep 3.
9
Novel autoantigens immunogenic in COPD patients.
Respir Res. 2009 Mar 12;10(1):20. doi: 10.1186/1465-9921-10-20.
10
Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease.
J Immunol. 2009 Mar 1;182(5):3270-7. doi: 10.4049/jimmunol.0802622.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验